NEW YORK (S&P Global Ratings) Dec. 6, 2016--S&P Global Ratings today assigned its 'BBB' issue-level rating to Zimmer Biomet Holdings Inc.'s announced offering of euro-denominated senior unsecured notes, to be issued in two tranches, maturing in 2022 and 2026. The company will use the proceeds from the offering to repay its 4.625% senior notes due 2019, 3.550% senior notes due 2025, 4.250% senior notes due 2035, 5.750% senior notes due 2039 and 4.450% senior notes due 2045, as well as for general corporate purposes. The transaction does not affect our 'BBB' corporate credit and senior unsecured debt ratings or our stable outlook on Zimmer Biomet, as we expect the transaction to be essentially leverage neutral. Our 'BBB' corporate credit rating